Mepilex® Border Sacrum Ag, 23cm x 23cm

SKU: 726382490

Status: Out of Stock

Case 25 (1)
Call For Price

 

Self-adherent antimicrobial soft silicone foam dressing

Mepilex Border Sacrum Ag consists of a Safetac® soft silicone wound contact layer, an absorbent polyurethane foam pad containing silver sulphate and coloured by activated carbon, a layer with super absorbent fibres, a nonwoven and a breathable and water proof film. Safetac® is a proprietary adhesive technology developed by Mölnlycke that minimises pain to patients and trauma to intact skin or wounds. Mepilex Border Sacrum Ag is a soft silicone foam dressing that absorbs exudate, maintains a moist wound healing environment and has antimicrobial properties. Mepilex Border Ag contains silver sulphate to create an effective bacterial barrier and inactivate a wide range of wound related pathogens (bacteria and fungi), as shown in vitro. By reducing the number of microorganisms, Mepilex Border Ag may also reduce odour. Mepilex Border Sacrum Ag has been shown to inactivate wound related pathogens up to 7 days in vitro.

  • Sterile
  • All-in-one
  • Antimicrobial
  • Foam
  • Soft silicone

Fast (as from 30 min, in vitro), sustained (up to 7 days, in vitro) and broad-range antimicrobial action (in vitro).1

Efficient exudate handling by minimizing leakage and high absorption, retention and MVTR. This could help reduce the number of dressing changes.2

 

More Info

More Info

  1. Mölnlycke Health Care. Data on File.
  2. Huss, F., Thorfinn, J. An open, non-controlled, postmarketing investigation evaluating the experience of using a self-adherent antimicrobial soft silicone, silver containing, foam dressing, Mepilex Border Ag, in second degree burns. PMCF study MxB Ag 02 from Mölnlycke Health Care. Unpublished data, 2011. Latenser, B., Alvarez, OM., Treadwell, T. Open multicentre investigation to evaluate signs and symptoms of local inflammation/infection on chronic ulcers and partial thickness burns when using Mepilex Border Ag as an anti-microbial wound dressing. PMCF study MxB Ag 01 from Mölnlycke Health Care. Unpublished data, 2012. Kles C.L., Murrah, C.P., Smith, K., Baugus- Wellmeier, E., Hurry, T., Morris, C.D. Achieving and sustaining zero. Preventing surgical site infections after isolated coronary artery bypass with saphenous vein harvest through implementation of a staffdriven quality improvement process. Dimensions of Critical Care Nursing 2015;34(5):265-272.

 

To top